Bankole A. Johnson

Neuroscience · Indiana University

Neurotransmitter Receptor Influence on Behavior Substance Abuse Treatment and Outcomes Alcohol Consumption and Health Effects Alcoholism and Thiamine Deficiency Forensic Toxicology and Drug Analysis

Publications

1,159

Citations

12,256

Est. group size

—

Recurring co-author estimate

Active years

Publishing since 1968

Publication cadence

Publications per year over the last 10 years — averaging 2.0/year recently

Recent publications

POS0781 EFFICACY AND SAFETY OF ORAL DEUCRAVACITINIB IN PATIENTS WITH CUTANEOUS MANIFESTATIONS OF LUPUS ERYTHEMATOSUS: RESULTS FROM PAISLEY CLE, A GLOBAL, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL
Annals of the Rheumatic Diseases · 2025
Safety and compliance of long-term low-dose ondansetron in alcohol use disorder treatment.
European Journal of Internal Medicine · 2024
Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes
European Journal of Internal Medicine · 2024
A critical scientific evaluation of a purportedly negative data report – response to Seneviratne et al. 2022
Frontiers in Psychiatry · 2023
A Prospective Precision Medicine Phase 3 Clinical Trial of Low-dose Ondansetron (a 5-ht3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder
Research Square · 2023
A Phase 3 Randomized Precision Medicine Clinical Trial Using Low-Dose Ondansetron (a 5-HT3 Antagonist) to Treat Alcohol Use Disorder
Research Square · 2023
Validation of serotonin transporter <scp>mRNA</scp> as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double‐blind, crossover trial
Alcoholism Clinical and Experimental Research · 2022
A Prospective Pharmacogenetic Phase 3 Clinical Trial of Low-Dose Ondansetron (A 5-HT3 Antagonist) to Treat Heavy and Very Heavy Drinkers With Alcohol Use Disorder
Research Square · 2022
A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis
Drug and Alcohol Dependence · 2021
Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials
JAMA Psychiatry · 2019
Statistical Analysis of Zero-Inflated Nonnegative Continuous Data: A Review
Statistical Science · 2019
Addiction Medicine: Science and Practice
2019
Variable selection for random effects two-part models
Statistical Methods in Medical Research · 2018
Toward Rational, Evidence‐Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use Disorder
Alcoholism Clinical and Experimental Research · 2017
<scp>FDA</scp> and <scp>EMA</scp> Need Homology on Alcohol Outcome Measures<i>—Semper: Simplicitas est purius modum</i>
Alcoholism Clinical and Experimental Research · 2017

Publishes in

Alcoholism Clinical and Experimental Research×3
Research Square×3
Physical Review Letters×2
European Journal of Internal Medicine×2
JAMA Psychiatry×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 9, 2026.

Claim or correct this profile